Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 12, 2022Journal of NeurochemistryOpen Access

The clinical pharmacology and potential therapeutic applications of 5‐methoxy‐N,N‐dimethyltryptamine (5‐MeO‐DMT)

View Full Paper
Ask AI
Bookmark
Share

Authors

JRJohannes T. ReckwegMaastricht UniversityMUMalin V. UthaugMaastricht UniversityASAttila SzabóOslo University Hospital

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Reckweg et al. (2022) studied this question.

synapsesocial.com/papers/69d98ea594760e72e6a3cf84https://doi.org/10.1111/jnc.15587
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Differentiation of 5-hydroxytryptamine2 receptor subtypes using 125I-R- (-)2,5-dimethoxy-4-iodo-phenylisopropylamine and 3H-ketanserin1989 · 102 citations
  2. 2Psychedelics and the Human Receptorome2010 · 309 citations
  3. 3Prolactin (PRL) and Its Receptor: Actions, Signal Transduction Pathways and Phenotypes Observed in PRL Receptor Knockout Mice1998 · 1,958 citations
  4. 4Innate immunity in vertebrates: an overview2016 · 443 citations
  5. 5The safety and efficacy of ±3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study2010 · 681 citations